Lamattina John L is a director of Immunome, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
LIGAND PHARMACEUTICALS INC
18 Jun 24
4
LIGAND PHARMACEUTICALS INC
13 Jun 23
4
Immunome Inc.
12 Jun 23
4
Immunome Inc.
17 Jan 23
4
LIGAND PHARMACEUTICALS INC
27 Dec 22
4
Immunome Inc.
21 Jun 22
4
LIGAND PHARMACEUTICALS INC
13 Jun 22
4
LIGAND PHARMACEUTICALS INC
17 Nov 21
4
LIGAND PHARMACEUTICALS INC
7 Jun 21
4
Immunome Inc.
1 Jun 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jun 24 | LGND Ligand Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 1,252 | 0.00 | 29,515 |
| 14 Jun 24 | LGND Ligand Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 80.06 | 5,444 | 435.85 k | 5,444 |
| 9 Jun 23 | LGND Ligand Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 1,142 | 0.00 | 28,263 |
| 9 Jun 23 | LGND Ligand Pharmaceuticals | NQSO Common Stock | Grant | Acquire A | No | No | 73.76 | 5,461 | 402.80 k | 5,461 |
| 8 Jun 23 | IMNM Immunome | Stock Option Common Stock | Grant | Acquire A | No | No | 4.84 | 6,500 | 31.46 k | 6,500 |